n this Axios column, Drew Altman presents a puzzle around corporate health costs: companies are talking like there is a crisis, but new data doesn’t really show it.
- view as grid
- view as list
This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.
Patients Could Still Be on the Hook for Outpatient Costs, Costs If They Test Negative, and Cost Sharing A new KFF analysis estimates that between 670,000 and 2 million uninsured people around the country eventually could be hospitalized with COVID-19, the respiratory disease caused by the novel coronavirus. Reimbursing hospitals…
This blog is an overview of the outstanding questions related to the $100 billion for hospitals and other providers in the CARES Act and whether there will be meaningful protections for the uninsured and people with private coverage who could face surprise bills.
Personal experiences with the health care system are a key factor in Americans’ opinions on how the health care system should function and their expectations of how the Affordable Care Act (ACA) will change the system when fully implemented. In order to take a closer look at these personal experiences,…
Kaiser December Tracking Poll: Public Remains Divided on Health Reform Law; Significant Number of People Struggle Financially
As 2010 draws to a close, the latest tracking poll from the Kaiser Family Foundation shows the public still divided in their views of the health reform law, a sentiment largely unchanged since the law’s enactment in March. Forty-two percent of Americans say they have a generally favorable view of…
The Kaiser Family Foundation will host a web conversation to discuss the drivers of recent and forecasted trends in prescription drug spending and examine how drug prices are set.
This Visualizing Health Policy infographic spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices. Prescription drug spending rose sharply in 2014, driven by growth in expenditures on specialty drugs, including medications to treat cancer and hepatitis C. Medicare’s spending on prescription pharmaceuticals also has risen, largely…
In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses how health care issues have cooled in the election season but matter more for certain voting groups than others, and for “health care voters” encompass more than the Affordable Care Act.
Puerto Rico: Datos Básicos provee una descripción general del las características demográficas, y estadísticas de salud y la economía. También se da alguna informacion del gobierno, reglas federales de Medicaid, y asuntos corrientes que estan afectando el territorio, incluyendo a Zika.